Antibiotic Tablet in pharma franchise in Uttarakhand

Antibiotic Tablet in PCD pharma franchise in Gandhinagar

Antibiotic Tablet in top pharma company in Faridabad

Antibiotic Tablet in pcd pharma supplier in Belagavi

Antibiotic Tablet in phama franchise company in India
Antibiotic Tablet in phama distributor in Kochi

Home/Products /amoxycillin-750mg-pantoprazole-40mg-clarithromycin-500mg-tablet

Panpital HP Kit

Composition : Amoxycillin (750mg) + Pantoprazole (40mg) + Clarithromycin (500mg)

Dosage Form : Tablet

Packaging Type : Each Kit Contains: 2 Tablet Each

Packaging : 10*1*1 Kit

Price : ₹233/-

Panpital HP Kit is a combination of Amoxicillin (750mg), Pantoprazole (40mg), and Clarithromycin (500mg), specifically designed for the eradication of Helicobacter pylori (H. pylori) infection, a common cause of peptic ulcers and gastritis. This triple-therapy regimen works synergistically to not only eliminate the H. pylori bacteria but also to reduce stomach acid, promoting healing and preventing further ulcer formation.

  • Amoxicillin is a broad-spectrum antibiotic that works by inhibiting bacterial cell wall synthesis, effectively targeting and killing H. pylori.
  • Pantoprazole is a proton pump inhibitor (PPI) that reduces gastric acid secretion, creating a less acidic environment, which helps to heal the stomach lining and esophagus while also enhancing the effectiveness of antibiotics.
  • Clarithromycin is another antibiotic that disrupts bacterial protein synthesis, providing a dual antibacterial effect along with amoxicillin, ensuring the complete eradication of the infection.

This combination therapy is effective in treating H. pylori-induced ulcers and preventing recurrence by eradicating the bacterial infection while reducing the stomach's acid load, aiding in the healing of the gastric mucosa.

Read More

About the Product

Panpital HP Kit is a combination of Amoxicillin (750mg), Pantoprazole (40mg), and Clarithromycin (500mg), specifically designed for the eradication of Helicobacter pylori (H. pylori) infection, a common cause of peptic ulcers and gastritis. This triple-therapy regimen works synergistically to not only eliminate the H. pylori bacteria but also to reduce stomach acid, promoting healing and preventing further ulcer formation.

  • Amoxicillin is a broad-spectrum antibiotic that works by inhibiting bacterial cell wall synthesis, effectively targeting and killing H. pylori.
  • Pantoprazole is a proton pump inhibitor (PPI) that reduces gastric acid secretion, creating a less acidic environment, which helps to heal the stomach lining and esophagus while also enhancing the effectiveness of antibiotics.
  • Clarithromycin is another antibiotic that disrupts bacterial protein synthesis, providing a dual antibacterial effect along with amoxicillin, ensuring the complete eradication of the infection.

This combination therapy is effective in treating H. pylori-induced ulcers and preventing recurrence by eradicating the bacterial infection while reducing the stomach's acid load, aiding in the healing of the gastric mucosa.

Common side effects include nausea, diarrhea, headache, and abdominal discomfort.

For the eradication of Helicobacter pylori infection associated with peptic ulcers.

Complete the full course of therapy as prescribed. Consult a doctor if symptoms persist or side effects occur.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation